Considerations for the use of imaging tools for phase II treatment trials in oncology.
about
A novel knowledge representation framework for the statistical validation of quantitative imaging biomarkersWhat we have learned: the impact of quality from a clinical trials perspectiveThe design of phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical trial design task force of the national cancer institute investigational drug steering committee.Effective incorporation of biomarkers into phase II trialsEvaluation of early imaging response criteria in glioblastoma multiforme.Comparison of the RECIST 1.0 and RECIST 1.1 in Non-Small Cell Lung Cancer Treated with Cytotoxic Chemotherapy.Effects of rigid and non-rigid image registration on test-retest variability of quantitative [18F]FDG PET/CT studiesNovel agents in renal carcinoma: a reality check.Comparison of the RECIST 1.0 and RECIST 1.1 in patients treated with targeted agents: a pooled analysis and review.Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review.Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volume.Pediatric oncology and the future of oncological imaging.Epigenetic therapy for solid tumors: from bench science to clinical trials.Comparison of the RECIST and EORTC PET criteria in the tumor response assessment: a pooled analysis and review.Comparison of the EORTC criteria and PERCIST in solid tumors: a pooled analysis and review.Performance of tumor growth kinetics as an imaging biomarker for response assessment in colorectal liver metastases: correlation with FDG PET.CORR Insights®: Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones?The clinical evaluation of novel imaging methods for cancer management.Voxel clustering for quantifying PET-based treatment response assessment.
P2860
Q26825076-8191CE36-5DDC-4410-A807-1B9CB178F134Q27008209-51F3EDB5-11D2-4487-A3DB-D2FBFCCF177CQ33732581-571821F9-7E9C-43D6-8110-3CBE0096D085Q33870594-1B9FA87E-D568-415C-A2F1-803FDBC7E7C7Q35289895-5A5BEBD8-B0C4-4765-9A8C-EC4D2415B0E5Q35739540-DE9A75FD-1615-4B74-9655-5703B8AB757BQ35950812-8F50E5A4-D244-4139-94F3-7341B7AE4661Q36061173-3512FF3F-361A-408B-962C-0CAE49166BF8Q37046433-AFF84495-1E28-4605-A87B-9C27FFCB40C9Q37317418-99690379-78BD-4A76-BE17-127549D494DCQ37495153-52B81749-9F83-40D1-A589-882825141784Q37869417-39718DC1-6747-44DC-B98F-BC24ED40D4F7Q38459836-6BEF3815-7D72-4CA6-BEBB-A62935F54B56Q38638528-224217B5-5381-48A3-BB0A-01AE990E0727Q38925824-54A59E09-F77B-4AB9-ABC8-E339C3D6BA50Q40557514-2EB32246-EBF5-48AB-B2AE-A0236C4A76D9Q42542315-ABDE98C9-B796-4400-807C-39FA9991A6A1Q50896909-66E41F39-F1F7-4BA7-9331-42716C095B24Q50920033-4169B005-39DD-4F75-967C-2C8C38B4E6B9
P2860
Considerations for the use of imaging tools for phase II treatment trials in oncology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Considerations for the use of imaging tools for phase II treatment trials in oncology.
@en
Considerations for the use of imaging tools for phase II treatment trials in oncology.
@nl
type
label
Considerations for the use of imaging tools for phase II treatment trials in oncology.
@en
Considerations for the use of imaging tools for phase II treatment trials in oncology.
@nl
prefLabel
Considerations for the use of imaging tools for phase II treatment trials in oncology.
@en
Considerations for the use of imaging tools for phase II treatment trials in oncology.
@nl
P2093
P1476
Considerations for the use of imaging tools for phase II treatment trials in oncology.
@en
P2093
Annick Van den Abbeele
Lalitha K Shankar
Robert Benjamin
Scott Scheutze
T J Fitzgerald
P304
P356
10.1158/1078-0432.CCR-08-2030
P407
P50
P577
2009-03-10T00:00:00Z